{"id":3908,"date":"2024-10-04T20:37:00","date_gmt":"2024-10-05T03:37:00","guid":{"rendered":"https:\/\/www.gigamune.com\/?p=3908"},"modified":"2025-02-04T20:43:38","modified_gmt":"2025-02-05T04:43:38","slug":"gigamune-wins-sbir-grant","status":"publish","type":"post","link":"https:\/\/www.gigamune.com\/?p=3908","title":{"rendered":"GigaMune wins eighth SBIR grant"},"content":{"rendered":"\n<p>GigaMune won its eighth SBIR grant, entitled \u201c<em>In vivo <\/em>Sickle Cell Disease Gene Therapy Using a Novel Virus Like Particle\u201d from the National Institute of Allergy and Infectious Diseases (NIAID). The project seeks to expand the capabilities of GigaMune\u2019s technology into delivery of curative transgenes to hematopoietic stem cells (HSCs). GigaMune\u2019s Founder and CEO Dr. David Johnson is principal investigator (PI) on the project. This is Dr. Johnson\u2019s twentieth SBIR grant as PI.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GigaMune won its eighth SBIR grant, entitled \u201cIn vivo Sickle Cell Disease Gene Therapy Using a Novel Virus Like Particle\u201d from the National Institute of Allergy and Infectious Diseases (NIAID). The project seeks to expand the capabilities of GigaMune\u2019s technology into delivery of curative transgenes to hematopoietic stem cells (HSCs). GigaMune\u2019s Founder and CEO Dr. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3881,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/www.gigamune.com\/index.php?rest_route=\/wp\/v2\/posts\/3908"}],"collection":[{"href":"https:\/\/www.gigamune.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gigamune.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gigamune.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gigamune.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3908"}],"version-history":[{"count":2,"href":"https:\/\/www.gigamune.com\/index.php?rest_route=\/wp\/v2\/posts\/3908\/revisions"}],"predecessor-version":[{"id":3910,"href":"https:\/\/www.gigamune.com\/index.php?rest_route=\/wp\/v2\/posts\/3908\/revisions\/3910"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gigamune.com\/index.php?rest_route=\/wp\/v2\/media\/3881"}],"wp:attachment":[{"href":"https:\/\/www.gigamune.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gigamune.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gigamune.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}